Gopi Shanker

Dr. Gopi Shanker is the Chief Scientific Officer of Beam Therapeutics. Dr. Shanker has more than two decades of broad drug discovery experience at Novartis, Amgen and Regeneron ranging from developing target concepts to advancing molecules through clinical development. He has contributed to the development of several clinical candidates and to the migraine drug, Aimovig®. With a strong background across multiple drug modalities including small molecules, biologics and gene therapies, he will bring great experience and leadership to the R&D teams. Dr. Shanker has a proven ability in successfully building, coaching, and developing cross-functional drug discovery teams as well as creating purpose-driven, highly productive research organizations. He is passionate about mentoring individuals and teams towards having high impact.